0000950170-23-066117.txt : 20231127 0000950170-23-066117.hdr.sgml : 20231127 20231127161505 ACCESSION NUMBER: 0000950170-23-066117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231122 FILED AS OF DATE: 20231127 DATE AS OF CHANGE: 20231127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khara Rahul CENTRAL INDEX KEY: 0001951850 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39438 FILM NUMBER: 231440409 MAIL ADDRESS: STREET 1: C/O DISC MEDICINE, INC. STREET 2: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Disc Medicine, Inc. CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 674-9274 MAIL ADDRESS: STREET 1: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE DATE OF NAME CHANGE: 20210209 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 4 1 ownership.xml 4 X0508 4 2023-11-22 0001816736 Disc Medicine, Inc. IRON 0001951850 Khara Rahul C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 false true false false General Counsel true Common Stock 2023-11-22 4 M false 10000 14.69 A 10000 D Common Stock 2023-11-22 4 S false 100 50.3400 D 9900 D Common Stock 2023-11-22 4 S false 9900 51.7474 D 0 D Stock Option (Right to Buy) 14.69 2023-11-22 4 M false 10000 0 D 2032-02-06 Common Stock 10000 79804 D These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $50.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.27 to $52.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Rahul Khara 2023-11-27